MRCP UK EXAMINATIONS

CLINICAL ENCOUNTERS

ANTICOAGULATION

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
Antiplatelet agents may prevent arterial thrombosis, myocardial infarction, or:
A
stroke
B
kidney failure
C
hemorrhage
D
perfusion
Explanation: 

Detailed explanation-1: -Antiplatelet drugs are intended to prevent and/or reverse platelet aggregation in arterial thrombosis, most prominently in myocardial infarction and ischaemic stroke.

Detailed explanation-2: -There are two classes of antithrombotic drugs: anticoagulants and antiplatelet drugs. Anticoagulants slow down clotting, thereby reducing fibrin formation and preventing clots from forming and growing. Antiplatelet agents prevent platelets from clumping and also prevent clots from forming and growing.

Detailed explanation-3: -Antiplatelet drugs work to make your platelets less sticky and thereby help prevent blood clots from forming in your arteries. Aspirin is an antiplatelet drug that may be used.

Detailed explanation-4: -Antiplatelet drugs inhibit platelet function, mostly platelet aggregation, which reduces the probability of thrombus formation (Depta 2015; Weitz 2012).

Detailed explanation-5: -Aspirin. P2Y12 Receptor Antagonists. Clopidogrel. Prasugrel. Ticagrelor. Cangrelor. PAR-1 Antagonists. Experimental Therapies. More items •14-Feb-2019

There is 1 question to complete.